EP3801028A4 - A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use - Google Patents
A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use Download PDFInfo
- Publication number
- EP3801028A4 EP3801028A4 EP19812212.9A EP19812212A EP3801028A4 EP 3801028 A4 EP3801028 A4 EP 3801028A4 EP 19812212 A EP19812212 A EP 19812212A EP 3801028 A4 EP3801028 A4 EP 3801028A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- msc
- frozen
- preparation
- methods
- growth factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000654 additive Substances 0.000 title 1
- 230000000996 additive effect Effects 0.000 title 1
- 239000003102 growth factor Substances 0.000 title 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Surgery (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Botany (AREA)
- Materials Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862677744P | 2018-05-30 | 2018-05-30 | |
US201862681172P | 2018-06-06 | 2018-06-06 | |
US201862688012P | 2018-06-21 | 2018-06-21 | |
US201862698673P | 2018-07-16 | 2018-07-16 | |
PCT/US2019/026595 WO2019231562A1 (en) | 2018-05-30 | 2019-04-09 | A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3801028A1 EP3801028A1 (en) | 2021-04-14 |
EP3801028A4 true EP3801028A4 (en) | 2022-04-13 |
Family
ID=68696768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19812212.9A Pending EP3801028A4 (en) | 2018-05-30 | 2019-04-09 | A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use |
Country Status (7)
Country | Link |
---|---|
US (1) | US20210196759A1 (en) |
EP (1) | EP3801028A4 (en) |
JP (1) | JP2021526556A (en) |
KR (1) | KR20210042268A (en) |
AU (1) | AU2019276713A1 (en) |
CA (1) | CA3101971A1 (en) |
WO (1) | WO2019231562A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11202106836UA (en) * | 2018-12-26 | 2021-07-29 | Direct Biologics Llc | Methods and compositions for treating skin and hair disorders |
SG11202108129SA (en) * | 2019-01-30 | 2021-08-30 | Direct Biologics Llc | Methods and compositions for developing target specific exosome and growth factor products |
WO2021011935A1 (en) * | 2019-07-18 | 2021-01-21 | Direct Biologics, Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
US12077780B2 (en) | 2020-02-14 | 2024-09-03 | Allergan Sales, Llc | Conditioned medium from cells cultured under hypoxic conditions and uses thereof |
AU2021251785A1 (en) * | 2020-04-07 | 2022-11-03 | Combangio, Inc. | Lyophilized mesenchymal stem cell derived secretome and uses thereof |
PL434626A1 (en) * | 2020-07-10 | 2022-01-17 | Bioceltix Spółka Akcyjna | Active protein encapsulation method using electrodeposition techniques, an antimicrobial composition containing the active protein and a polymer, and its use in production of veterinary medicinal products |
PL434622A1 (en) * | 2020-07-10 | 2022-01-17 | Bioceltix Spółka Akcyjna | Active protein encapsulation method using electrodeposition techniques, an immunomodulating composition containing the active protein and a polymer, and use thereof for preparation of a veterinary composition for treatment of atopic dermatitis in animals |
PL434624A1 (en) * | 2020-07-10 | 2022-01-17 | Bioceltix Spółka Akcyjna | Method of encapsulating a protein active substance using electrodeposition techniques, an antimicrobial composition containing a protein active substance and a polymer, and its use in production of medicinal products for human use |
PL434621A1 (en) * | 2020-07-10 | 2022-01-17 | Bioceltix Spółka Akcyjna | Active protein encapsulation method using electrodeposition techniques, an immunomodulating composition containing the active protein and a polymer, and its use for the preparation of a pharmaceutical composition for treatment of human atopic dermatitis |
IT202000017746A1 (en) * | 2020-07-22 | 2022-01-22 | ALGO BIOTECHNOLOGIES srl | PHARMACEUTICAL COMPOSITION COMPRISING MEDIA CONDITIONED BY SECRETOMA OF MESENCHIMAL CELLS OF THE ORAL CAVITY |
IT202100005438A1 (en) * | 2021-03-09 | 2022-09-09 | Pharmaexceed S R L | SCAFFOLD FOR BONE REGENERATION AND RELATED MANUFACTURING METHOD |
WO2023033500A1 (en) * | 2021-08-30 | 2023-03-09 | 가톨릭대학교 산학협력단 | Composition for preventing or treating ocular surface inflammatory disorders, containing extracellular vesicles |
JP2023138461A (en) * | 2022-03-16 | 2023-10-02 | フィブロバイオロジクス インコーポレイテッド | Therapeutic use of fibroblasts for use in wound healing |
CN117618658A (en) * | 2023-12-08 | 2024-03-01 | 中国人民解放军总医院 | Preparation method and application of exosome enrichment bracket |
CN118161450B (en) * | 2024-05-11 | 2024-08-30 | 北京益华生物科技有限公司 | Atomized preparation containing cell active factors and application of atomized preparation in acute pneumonia |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012142569A2 (en) * | 2011-04-15 | 2012-10-18 | The Regents Of The University Of California | Decellularized extracellular matrix |
US20130210725A1 (en) * | 1999-05-14 | 2013-08-15 | Allergan, Inc. | Conditioned cell culture medium compositions and methods of use |
WO2015031110A2 (en) * | 2013-08-27 | 2015-03-05 | The Regents Of The University Of California | Combination therapy to promote wound healing |
WO2016082882A1 (en) * | 2014-11-27 | 2016-06-02 | Med Cell Europe Ag | Secretomes and method for producing secretomes |
WO2018038575A1 (en) * | 2016-08-26 | 2018-03-01 | 연세대학교 산학협력단 | Pharmaceutical composition for treating rheumatoid arthritis, comprising mesenchymal stem cell-derived secretory proteome, and therapeutic method using same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1641913B1 (en) * | 2003-06-27 | 2016-01-06 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
WO2006121445A2 (en) * | 2005-05-10 | 2006-11-16 | United States Of America Department Of Veteran's Affairs | Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media |
US8372797B2 (en) * | 2006-06-22 | 2013-02-12 | Creative Medical Health, Inc. | Treatment of erectile dysfunction by stem cell therapy |
JP6204830B2 (en) * | 2011-03-11 | 2017-09-27 | チルドレンズ メディカル センター コーポレーション | Methods and compositions related to mesenchymal stem cell exosomes |
WO2017117585A1 (en) * | 2015-12-30 | 2017-07-06 | The Regents Of The University Of California | Methods for enhanced production and isolation of cell-derived vesicles |
WO2017139795A1 (en) * | 2016-02-12 | 2017-08-17 | Cell Care Therapeutics | Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same |
KR20190109389A (en) * | 2016-11-03 | 2019-09-25 | 엑소스템 바이오텍 리미티드 | Mesenchymal stem cell populations, products thereof, and uses thereof |
-
2019
- 2019-04-09 AU AU2019276713A patent/AU2019276713A1/en active Pending
- 2019-04-09 EP EP19812212.9A patent/EP3801028A4/en active Pending
- 2019-04-09 CA CA3101971A patent/CA3101971A1/en active Pending
- 2019-04-09 WO PCT/US2019/026595 patent/WO2019231562A1/en unknown
- 2019-04-09 US US17/059,874 patent/US20210196759A1/en active Pending
- 2019-04-09 KR KR1020207037839A patent/KR20210042268A/en unknown
- 2019-04-09 JP JP2021517548A patent/JP2021526556A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130210725A1 (en) * | 1999-05-14 | 2013-08-15 | Allergan, Inc. | Conditioned cell culture medium compositions and methods of use |
WO2012142569A2 (en) * | 2011-04-15 | 2012-10-18 | The Regents Of The University Of California | Decellularized extracellular matrix |
WO2015031110A2 (en) * | 2013-08-27 | 2015-03-05 | The Regents Of The University Of California | Combination therapy to promote wound healing |
WO2016082882A1 (en) * | 2014-11-27 | 2016-06-02 | Med Cell Europe Ag | Secretomes and method for producing secretomes |
WO2018038575A1 (en) * | 2016-08-26 | 2018-03-01 | 연세대학교 산학협력단 | Pharmaceutical composition for treating rheumatoid arthritis, comprising mesenchymal stem cell-derived secretory proteome, and therapeutic method using same |
Non-Patent Citations (5)
Title |
---|
CUNNINGHAM CATRIONA J ET AL: "The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke", JOURNAL OF CEREBRAL BLOOD FLOW & METABOLISM, vol. 38, no. 8, 17 May 2018 (2018-05-17), US, pages 1276 - 1292, XP055897226, ISSN: 0271-678X, Retrieved from the Internet <URL:http://journals.sagepub.com/doi/full-xml/10.1177/0271678X18776802> DOI: 10.1177/0271678X18776802 * |
JORGE M SANTOS ET AL: "Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing", STEM CELL RESEARCH & THERAPY, BIOMED CENTRAL LTD, LONDON, UK, vol. 6, no. 1, 9 May 2015 (2015-05-09), pages 90, XP021223497, ISSN: 1757-6512, DOI: 10.1186/S13287-015-0082-5 * |
JULIANTO INDAH ET AL: "Topical Delivery of Mesenchymal Stem Cells "Secretomes" in Wound Repair", ACTA MEDICA INDONESIANA, vol. 48, no. 3, 1 July 2016 (2016-07-01), IN, pages 217 - 220, XP055898006, ISSN: 0125-9326 * |
See also references of WO2019231562A1 * |
XIA XIANFENG ET AL: "Secretome from hypoxia-conditioned adipose-derived mesenchymal stem cells promotes the healing of gastric mucosal injury in a rodent model", BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE, vol. 1864, no. 1, 6 October 2017 (2017-10-06), pages 178 - 188, XP085287628, ISSN: 0925-4439, DOI: 10.1016/J.BBADIS.2017.10.009 * |
Also Published As
Publication number | Publication date |
---|---|
CA3101971A1 (en) | 2019-12-05 |
EP3801028A1 (en) | 2021-04-14 |
US20210196759A1 (en) | 2021-07-01 |
WO2019231562A1 (en) | 2019-12-05 |
AU2019276713A1 (en) | 2021-01-21 |
JP2021526556A (en) | 2021-10-07 |
KR20210042268A (en) | 2021-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3801028A4 (en) | A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use | |
EP3799571A4 (en) | Biogum and botanical gum hydrogel bioinks for the physiological 3d bioprinting of tissue constructs for in vitro culture and transplantation | |
EP3746785A4 (en) | Organoids related to immunotherapy and methods of preparing and using the same | |
EP3294307A4 (en) | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them | |
EP3843720A4 (en) | Compositions of cxcr4 inhibitors and methods of preparation and use | |
EP3007655A4 (en) | Acetabular cup prosthesis positioning instrument and method | |
EP3801531A4 (en) | Low glycemic gummy composition and methods of making and using thereof | |
EP3589293A4 (en) | Differentiation and use of human microglia-like cells from pluripotent stem cells and hematopoietic progenitors | |
EP3772256A4 (en) | System and methods for preparation of adipose-derived stem cells | |
EP3815540A4 (en) | Sweetener powder composition and preparation method therefor | |
EP3861097A4 (en) | Artificial human pulmonary airway and methods of preparation | |
EP3008993A4 (en) | Method for inducing artificial ovulation and spawning of fresh-water eels | |
EP3812378A4 (en) | Crystal form of arn-509, preparation method therefor and use thereof | |
EP3609997A4 (en) | Multi donor stem cell compositions and methods of making same | |
EP3947688A4 (en) | T cell receptors and methods of use thereof | |
EP3939615A4 (en) | Preparation method and use for artificial exocrine complex | |
EP3658278A4 (en) | Crystalline metallophosphates, their method of preparation, and use | |
EP3968975A4 (en) | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same | |
EP3812457A4 (en) | Method for preparing pellets of chondrocytes from human induced pluripotent stem cells, and use thereof | |
EP3572399A4 (en) | Crystal form of gft-505 and preparation method and use thereof | |
EP4074819A4 (en) | Method for preparation of mesenchymal stem cell from human pluripotent stem cell and mesenchymal stem cells prepared thereby | |
EP3903730A4 (en) | Covered stent and preparation method therefor | |
EP3840725A4 (en) | Methods and compositions to increase hair growth and/or prevent hair loss | |
EP3802797A4 (en) | Methods of making natural killer cells and uses thereof | |
EP3780973A4 (en) | Compositions and methods of use thereof to promote muscle growth and function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20201221 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40050264 Country of ref document: HK |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A01N0061000000 Ipc: A61K0035280000 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220316 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 29/00 20060101ALI20220310BHEP Ipc: A61P 17/02 20060101ALI20220310BHEP Ipc: A61P 15/00 20060101ALI20220310BHEP Ipc: A61K 35/14 20150101ALI20220310BHEP Ipc: A61K 35/32 20150101ALI20220310BHEP Ipc: A61K 35/30 20150101ALI20220310BHEP Ipc: A61K 35/28 20150101AFI20220310BHEP |